What does LECLERCQ-HICK MEDICALE do?

LECLERCQ-HICK MEDICALE is a specialist medical practice in Beyne-Heusay. Private Limited, started on 27 March 2007, 1 establishment.

What is the address of LECLERCQ-HICK MEDICALE?

The registered office of LECLERCQ-HICK MEDICALE is located at Rue des Roitelets 25, 4610 Beyne-Heusay.

Is LECLERCQ-HICK MEDICALE still active?

Yes. According to the CBE (16 September 2026) LECLERCQ-HICK MEDICALE is active, legal situation “Normale toestand”, started on 27 March 2007.

Is LECLERCQ-HICK MEDICALE registered on Peppol?

Yes, LECLERCQ-HICK MEDICALE is registered on the Peppol network with ID 0208:0888286408.

What is the enterprise number of LECLERCQ-HICK MEDICALE?

The enterprise number of LECLERCQ-HICK MEDICALE is BE0888286408.

When was LECLERCQ-HICK MEDICALE founded?

LECLERCQ-HICK MEDICALE was founded on 27 March 2007.

Who are the directors of LECLERCQ-HICK MEDICALE?

According to the 2025 annual accounts, the directors of LECLERCQ-HICK MEDICALE are: Gaëtane HICK, Pascal LECLERCQ.

Is LECLERCQ-HICK MEDICALE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 March 2007; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did LECLERCQ-HICK MEDICALE make in 2025?

LECLERCQ-HICK MEDICALE posted a profit after taxes of € 46,056 in financial year 2025.

What is the revenue of LECLERCQ-HICK MEDICALE?

As a small company, LECLERCQ-HICK MEDICALE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 206,466.

LECLERCQ-HICK MEDICALE (Private Limited) - Beyne-Heusay

Dossier LECLERCQ-HICK MEDICALE, printed on 16 September 2026 from databakkes.be/en/0888286408/leclercq-hick-medicale. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

LECLERCQ-HICK MEDICALE from Beyne-Heusay, company number BE0888286408, closed financial year 2025 with a result of € 46,056 after tax. For that financial year LECLERCQ-HICK MEDICALE recorded a gross margin of € 206,466 and equity of € 399,514. Compared with financial year 2024, the result moved from € 79,943 to € 46,056. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 29, 2025.

What it is worth Growing

€ 399,514

▲ 13% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 46,056

▼ 42% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 177,837

▼ 52% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 393,314.

People and assets in 2025

Vehicles and equipment

€ 155,854

▲ € 131,031 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 101,369

€ 21,413 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 275,313 Gross margin 2022: € 275,313 First fiscal year in the series	€ 242,844 Gross margin 2023: € 242,844 ▼ 12% vs 2022 (€ 275,313) Unfavourable step	€ 255,749 Gross margin 2024: € 255,749 ▲ 5% vs 2023 (€ 242,844) Favourable step	€ 206,466 Gross margin 2025: € 206,466 ▼ 19% vs 2024 (€ 255,749) Unfavourable step	▼ 19%
Profit after taxes	€ 134,552 Profit after taxes 2022: € 134,552 First fiscal year in the series	€ 76,566 Profit after taxes 2023: € 76,566 ▼ 43% vs 2022 (€ 134,552) Unfavourable step	€ 79,943 Profit after taxes 2024: € 79,943 ▲ 4% vs 2023 (€ 76,566) Favourable step	€ 46,056 Profit after taxes 2025: € 46,056 ▼ 42% vs 2024 (€ 79,943) Unfavourable step	▼ 42%
Equity	€ 325,949 Equity 2022: € 325,949 First fiscal year in the series	€ 342,515 Equity 2023: € 342,515 ▲ 5% vs 2022 (€ 325,949) Favourable step	€ 353,458 Equity 2024: € 353,458 ▲ 3% vs 2023 (€ 342,515) Favourable step	€ 399,514 Equity 2025: € 399,514 ▲ 13% vs 2024 (€ 353,458) Favourable step	▲ 13%
Total debts	€ 173,023 Total debts 2022: € 173,023 First fiscal year in the series	€ 239,281 Total debts 2023: € 239,281 ▲ 38% vs 2022 (€ 173,023) Unfavourable step	€ 235,643 Total debts 2024: € 235,643 ▼ 2% vs 2023 (€ 239,281) Favourable step	€ 324,431 Total debts 2025: € 324,431 ▲ 38% vs 2024 (€ 235,643) Unfavourable step	▲ 38%
Cash	€ 281,387 Cash 2022: € 281,387 First fiscal year in the series	€ 389,987 Cash 2023: € 389,987 ▲ 39% vs 2022 (€ 281,387) Favourable step	€ 373,616 Cash 2024: € 373,616 ▼ 4% vs 2023 (€ 389,987) Unfavourable step	€ 177,837 Cash 2025: € 177,837 ▼ 52% vs 2024 (€ 373,616) Unfavourable step	▼ 52%
Retained profit	€ 319,749 Retained profit 2022: € 319,749 First fiscal year in the series	€ 336,315 Retained profit 2023: € 336,315 ▲ 5% vs 2022 (€ 319,749) Favourable step	€ 347,258 Retained profit 2024: € 347,258 ▲ 3% vs 2023 (€ 336,315) Favourable step	€ 393,314 Retained profit 2025: € 393,314 ▲ 13% vs 2024 (€ 347,258) Favourable step	▲ 13%
Dividend	€ 140,000 Dividend 2022: € 140,000 First fiscal year in the series	€ 60,000 Dividend 2023: € 60,000 ▼ 57% vs 2022 (€ 140,000) Unchanged	€ 69,000 Dividend 2024: € 69,000 ▲ 15% vs 2023 (€ 60,000) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 69,000) Unchanged	▼ 100%
Bank debt	€ 22,369 Bank debt 2022: € 22,369 First fiscal year in the series	€ 11,246 Bank debt 2023: € 11,246 ▼ 50% vs 2022 (€ 22,369) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 11,246) Favourable step	€ 101,369 Bank debt 2025: € 101,369 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 498,972 Balance sheet total 2022: € 498,972 First fiscal year in the series	€ 581,796 Balance sheet total 2023: € 581,796 ▲ 17% vs 2022 (€ 498,972) Unchanged	€ 589,101 Balance sheet total 2024: € 589,101 ▲ 1% vs 2023 (€ 581,796) Unchanged	€ 723,945 Balance sheet total 2025: € 723,945 ▲ 23% vs 2024 (€ 589,101) Unchanged	▲ 23%

Key figures of LECLERCQ-HICK MEDICALE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 October 2026.

What happened to LECLERCQ-HICK MEDICALE?

What happened at LECLERCQ-HICK MEDICALE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 29, 2025 New annual accounts for financial year 2025: profit of € 46,056 (▼ 42% vs 2024). Source: NBB ↗
Mar 27, 2007 New establishment in Beyne-Heusay. KBO
Mar 27, 2007 Start of the company according to the CBE. KBO

In short

From € 134,552 profit in 2022 to € 46,056 profit in 2025.

Paid € 127,158 in corporate taxes since 2022.

Best year ever: 2022, with € 134,552 profit.

Paid out € 269,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at LECLERCQ-HICK MEDICALE? We notify you, reason included.

Follow LECLERCQ-HICK MEDICALE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Gaëtane HICK Pascal LECLERCQ

LECLERCQ-HICK MEDICALE

Behind LECLERCQ-HICK MEDICALE are Gaëtane HICK and Pascal LECLERCQ.

See the full network in the app

Directors

According to the 2025 annual accounts

Gaëtane HICK

Director

Pascal LECLERCQ

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue des Roitelets 25

4610 Beyne-Heusay

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0888.286.408
VAT number: BE 0888.286.408
Registered office: Rue des Roitelets 25, 4610 Beyne-Heusay
Names & denominations: LECLERCQ-HICK MEDICALE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 27 March 2007
Peppol: Active · Active since 5 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗